Vimarsana
Biggest News Aggregation in the World

Ashanthi Mathai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ashanthi Mathai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ashanthi Mathai Today - Breaking & Trending Today

NaxSwab™ OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone from an opioid overdose in study - Vimarsana News

NaxSwab™ OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone from an opioid overdose in study

Published: April 13, 2023

/PRNewswire/ -- Pocket Naloxone Corp., a startup pharmaceutical company with the vision of enhancing naloxone delivery, announced results from a human factors...

Source: prnewswire.com
Related Topics:
Ashanthi MathaiPrnewswire Pocket Naloxone CorpAdvisory CommitteeEurofins Human FactorsNaloxone CorpHuman Factors Validation StudyAdult PatientsLay CaregiversPocket NaloxonePocket Naloxone Corp
NaxSwab™ OTC novel naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study - Vimarsana News

NaxSwab™ OTC novel naloxone nasal swab demonstrates faster absorption and higher early exposures against other naloxone products in clinical study

Published: December 1, 2022

/PRNewswire/ -- Pocket Naloxone Corp., a startup pharmaceutical company with the vision of enhancing naloxone delivery, today announced positive results from...

Source: prnewswire.com
Related Topics:
United StatesAshanthi MathaiAndrea BarthwellKathleen Van GordenAmerican Society For Addiction MedicinePrnewswire Pocket Naloxone CorpDrug AdministrationNaloxone CorpNational Sales PerspectivesPocket NaloxoneBoard LiaisonAmerican SocietyAddiction MedicineDeputy DirectorDemand ReductionWhite House OfficeNational Drug ControlFederal RegisterCertain Naloxone Hydrochloride Drug ProductsNonprescription UseSales PerspectivesPocket Naloxone Corp